EirGen Pharma is a pharmaceutical company which specialises in the development, registration and commercial supply of highly potent pharmaceutical products that require high levels of containment.
The company’s purpose built high containment facility, utilising innovative isolation technology is fully licensed to develop and supply the following types of molecules in finished dosage form:
- Cytotoxins / Cytostatics.
Their state of the art facilities can also facilitate the development of moisture sensitive molecules in an environment below 30%RH. The facility is EU EMEA, US FDA & Japanese PMDA approved.
- Out-licensing of niche, high barrier to entry products in CTD format.
- High potency product development and commercial supply on a contract or collaboration basis.
- Manufacture of Clinical Trial supplies.